DICABS Board Approves Financial Results, Welcomes New CFO
DICABS announced its audited financial results for the quarter and fiscal year ending March 31, 2026. The Board of Directors approved these…
E.I.D. Parry (India) Limited Announces Audited Financial Results for FY 2025-2026
E.I.D. Parry (India) Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company’s…
Union Bank of India Board Approves Capital Raising Plan of Up to ₹8,000 Crore
Union Bank of India’s Board of Directors has approved a capital raising plan of up to ₹8,000 crore. This plan includes raising equity…
Kaveri Seed Company Limited Announces Audited Financial Results for FY 2025-2026
Kaveri Seed Company Limited has officially released its audited standalone and consolidated financial results for the fiscal year ending March…
Marksans Pharma Ltd. Declares FY26 Audited Financial Results and Recommends Dividend
Marksans Pharma Ltd. announced its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The…
Refex Industries Limited Board Approves Audited Financial Results and Recommends Final Dividend
Refex Industries Limited announced its audited financial results for the fourth quarter and fiscal year ended March 31, 2026. The Board of…
ASTRA MICROWAVE PRODUCTS LIMITED Audited Financial Results for FY 2025-26 and Dividend Recommendation
ASTRA MICROWAVE PRODUCTS LIMITED announced its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.…
Tilaknagar Industries Ltd Board Meeting Scheduled for May 29, 2026
Tilaknagar Industries Ltd. has scheduled a meeting of its Board of Directors for Friday, May 29, 2026. The primary agenda for the meeting…
Sundaram Finance Board Approves Tier 2 Capital Raise of ₹500 Crore
Sundaram Finance has announced that its Board of Directors has approved a proposal to raise ₹500 crore in Tier 2 capital. This fundraise will…
Aarti Pharmalabs Full Year Financial Results and Strategic Leadership Updates
Aarti Pharmalabs reported its financial performance for the year ended March 31, 2026, announcing a final dividend of Rs. 2 per equity share…